ArticleBritish journal of pharmacology2021

Bletinib ameliorates neutrophilic inflammation and lung injury by inhibiting Src family kinase phosphorylation and activity.

Ting-I Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.